|
HOOK3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.203000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.925600E-01 |
| Normal-vs-Stage2 |
1.559920E-02 |
| Normal-vs-Stage3 |
3.311000E-01 |
| Normal-vs-Stage4 |
7.429600E-01 |
| Stage1-vs-Stage2 |
1.032120E-02 |
| Stage1-vs-Stage3 |
3.523000E-01 |
| Stage1-vs-Stage4 |
5.287800E-01 |
| Stage2-vs-Stage3 |
6.651600E-02 |
| Stage2-vs-Stage4 |
1.216100E-02 |
| Stage3-vs-Stage4 |
2.032600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.393000E-01 |
| Normal-vs-AfricanAmerican |
3.150600E-01 |
| Normal-vs-Asian |
8.313800E-01 |
| Caucasian-vs-AfricanAmerican |
1.928570E-01 |
| Caucasian-vs-Asian |
9.578000E-01 |
| AfricanAmerican-vs-Asian |
3.016200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.930800E-01 |
| Normal-vs-Female |
5.911400E-01 |
| Male-vs-Female |
6.730600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.999400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.409400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.996840E-01 |
| Normal-vs-Age(81-100Yrs) |
8.271600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.698100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.946300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.342310E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.219400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.314000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.757810E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.769000E-01 |
| Classical-VS-Follicular |
8.0618000053434E-09 |
| Classical-VS-Other |
5.499400E-01 |
| Classical-VS-Normal |
5.521800E-01 |
| Tall-VS-Follicular |
8.368100E-04 |
| Tall-VS-Other |
6.089200E-01 |
| Tall-VS-Normal |
8.522800E-01 |
| Follicular-VS-Other |
1.706790E-01 |
| Follicular-VS-Normal |
2.438600E-04 |
| Other-VS-Normal |
7.027600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.922300E-02 |
| Normal-vs-N1 |
3.070800E-01 |
| N0-vs-N1 |
1.224170E-03 |
|
|
